Acadia Healthcare Company Inc.

Acadia Healthcare Company Inc. is a publicly traded provider of specialty behavioral health services in the United States, founded in 1987 and headquartered in Franklin, Tennessee, United States. The company operates over 180 facilities that deliver inpatient psychiatric care, residential addiction treatment, and outpatient mental health services. Under Interim CEO Kevin Truitt, Acadia emphasizes integrated treatment models and digital health innovations. This diversified approach positions the company to effectively navigate regulatory pressures and capitalize on growth opportunities in the evolving healthcare market.

On February 25, 2025, Acadia's board authorized a $300.0 million share repurchase program with no termination date; during the year ended December 31, 2025 the Company repurchased 1,706,625 shares for $50.4 million, leaving $250.0 million remaining as of December 31, 2025.

For the year ended December 31, 2025, the Company received 57.7% of revenue from Medicaid, 24.6% from commercial payors, 14.3% from Medicare and 3.4% from other payors. No facility accounted for more than 4% of revenue, and no state or U.S. territory accounted for more than 14% of revenue, for the year ended December 31, 2025; revenue from Pennsylvania, Tennessee and California represented approximately 13%, 10% and 8% of total revenue, respectively.